Long‐Term Retention in an Outpatient Behavioral Health Clinic With Buprenorphine-Reference-Cited by-同舟云学术

Long‐Term Retention in an Outpatient Behavioral Health Clinic With Buprenorphine

Published:2019-05-08 Issue:5 Volume:28 Page:339-346
ISSN:1055-0496
Container-title:The American Journal on Addictions
language:en
Short-container-title:Am J Addict

Author:

Montalvo Cristina¹²^ORCID,Stankiewicz Brad³,Brochier Annelise⁴,Henderson David C.²⁵,Borba Christina P.C.²⁵

Affiliation:

1. Department of PsychiatryVA Boston Healthcare System West Roxbury Massachusetts

2. Department of PsychiatryBoston University School of Medicine Boston Massachusetts

3. Department of PsychiatryBournewood Health Systems Brookline Massachusetts

4. Department of PediatricsBoston Medical Center Boston Massachusetts

5. Department of PsychiatryBoston Medical Center Boston Massachusetts

Funder

Center for Mental Health Services

Substance Abuse and Mental Health Services Administration

Publisher

Wiley

Subject

Psychiatry and Mental health,Clinical Psychology,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajad.12896

Reference30 articles.

1. Substance Abuse and Mental Health Services Administration.Key Substance Use and Mental Health Indicators in the United States: Results From the 2016 National Survey on Drug Use and Health. Rockville MD;2017. HHS Publication No. SMA 17–5044 NSDUH Series H‐52.

2. Primary Care–Based Buprenorphine Taper vs Maintenance Therapy for Prescription Opioid Dependence

3. Collaborative Care of Opioid-Addicted Patients in Primary Care Using Buprenorphine

4. Leaving buprenorphine treatment: Patients' reasons for cessation of care

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial;International Journal of Drug Policy;2024-05

2. Barriers to retention in medications for opioid use disorder treatment in real-world practice;Journal of Substance Use and Addiction Treatment;2024-05

3. Nine-year substance use treatment outcomes with buprenorphine for opioid use disorder in a federally qualified health center;Drug and Alcohol Dependence;2024-04

4. Medical and genetic correlates of long-term buprenorphine treatment in the electronic health records;Translational Psychiatry;2024-01-10

5. Trends and Barriers of Medication Treatment for Opioid Use Disorders: A Systematic Review and Meta-Analysis;Journal of Drug Issues;2023-10-11